UK markets open in 1 hour 13 minutes

UroGen Pharma Ltd. (URGN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.78-0.19 (-1.12%)
At close: 04:00PM EDT
16.78 0.00 (0.00%)
After hours: 04:24PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-104,317
-102,244
-109,783
-110,820
-128,484
-
Depreciation & amortisation
1,621
1,705
1,817
1,773
2,044
-
Stock-based compensation
9,813
9,343
10,580
23,113
28,025
-
Change in working capital
563
3,336
-6,306
-14,282
-6,369
-
Accounts receivable
-1,665
-2,739
-987
-4,671
-7,047
-
Inventory
-1,778
-1,348
-362
-2,868
-1,964
-
Accounts payable
1,028
4,155
281
1,998
-1,245
-
Other working capital
-82,475
-76,570
-87,813
-85,644
-107,101
-
Other non-cash items
-351
1,014
2,624
-1,176
-1,541
-
Net cash provided by operating activities
-82,304
-76,376
-87,559
-84,892
-105,886
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-194
-254
-752
-1,215
-
Purchases of investments
-25,656
-49,832
-63,009
-51,898
-29,688
-
Sales/maturities of investments
32,122
49,073
64,323
56,719
124,141
-
Other investing activities
-172
-
-
-
-
-172
Net cash used for investing activities
6,295
-953
1,060
4,069
93,238
-
Cash flows from financing activities
Common stock issued
122,015
67,358
0
0
15,853
-
Other financing activities
-
-
-160
72,258
-66
-76
Net cash used provided by (used for) financing activities
170,917
116,931
97,134
72,319
16,527
-
Net change in cash
94,908
39,602
10,635
-8,504
3,879
-
Cash at beginning of period
37,354
56,221
45,586
54,090
50,211
-
Cash at end of period
132,262
95,823
56,221
45,586
54,090
-
Free cash flow
Operating cash flow
-82,304
-76,376
-87,559
-84,892
-105,886
-
Capital expenditure
-
-194
-254
-752
-1,215
-
Free cash flow
-82,475
-76,570
-87,813
-85,644
-107,101
-